We are live on
!
Find out more
ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
705 hedge funds and large institutions have $22.4B invested in Alexion Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 123 funds opening new positions, 248 increasing their positions, 247 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
86% more first-time investments, than exits
New positions opened: 123 | Existing positions closed: 66
24% more capital invested
Capital invested by funds: $18B → $22.4B (+$4.37B)
11% more funds holding in top 10
Funds holding in top 10: 19 → 21 (+2)
8% more funds holding
Funds holding: 653 → 705 (+52)
0% more repeat investments, than reductions
Existing positions increased: 248 | Existing positions reduced: 247
19% less call options, than puts
Call options by funds: $305M | Put options by funds: $378M
Holders
705
Holders Change
+52
Holders Change %
+7.96%
% of All Funds
14.46%
Holding in Top 10
21
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+10.53%
% of All Funds
0.43%
New
123
Increased
248
Reduced
247
Closed
66
Calls
$305M
Puts
$378M
Net Calls
-$72.3M
Net Calls Change
+$15.6M
Top Buyers
| 1 |
LSV Asset Management
Chicago,
Illinois
|
+$281M |
| 2 |
BlackRock
New York
|
+$214M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$119M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$106M |
| 5 |
JP Morgan Chase
New York
|
+$92.4M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$185M |
| 2 |
Ninety One (UK)
London,
United Kingdom
|
-$144M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$117M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$113M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$95.7M |
